{
    "clinical_study": {
        "@rank": "154777", 
        "arm_group": {
            "arm_group_label": "Tablet-based reported outcome", 
            "arm_group_type": "Experimental", 
            "description": "With the start of chemotherapy until the end of the last cycle of chemotherapy the study participants have to document all signs of discomfort or changes to their overall coenesthesia in the tablet-based questionnaire."
        }, 
        "brief_summary": {
            "textblock": "This study is a single arm feasibility study. Patients that have been diagnosed with\n      carcinoma and are undergoing chemotherapy have to document chemotherapy associated side\n      effects on a regular basis by means of a tablet-based online questionnaire. Goal of the\n      study is to find out if patients that are undergoing chemotherapy are willing to document\n      chemotherapy associated side effects by means of a tablet-based online questionnaire."
        }, 
        "brief_title": "Tablet-based Patient Reported Outcome", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Antineoplastic Agents", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients have to be \u2265 18 years of age\n\n          -  written consent form and agreement to participate in the study\n\n          -  patients that are able to follow the study instructions and that most likely will\n             keep the required study appointments\n\n          -  patients that have a histological confirmed carcinoma and are scheduled to undergo\n             adjuvant or neoadjuvant chemotherapy of 6 to 8 cycles\n\n          -  questions about chemotherapy associated side effects are composed in german.\n             Therefore the study participants must have sufficient knowledge of the german\n             language\n\n          -  ECOG maximal level 2\n\n        Exclusion Criteria:\n\n          -  patients that are younger than 18 years\n\n          -  patients that don't agree to take part of the study\n\n          -  patients that are not able to understand the scope, the meaning and the consequences\n             of that clinical study\n\n          -  patients that have a known or constant addiction to drugs or alcohol\n\n          -  patients that suffer from blindness or dyslexia"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "57", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01991691", 
            "org_study_id": "TabPRO I"
        }, 
        "intervention": {
            "arm_group_label": "Tablet-based reported outcome", 
            "description": "tablet-based patient reported outcomes (TabPRO)", 
            "intervention_name": "Tablet-based questionnaire", 
            "intervention_type": "Device"
        }, 
        "intervention_browse": {
            "mesh_term": "Antineoplastic Agents"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Antineoplastic Agents", 
        "lastchanged_date": "November 25, 2013", 
        "location": [
            {
                "contact": {
                    "email": "michael.mallmann@uni-bonn.de", 
                    "last_name": "Michael Mallmann, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Bonn", 
                        "country": "Germany", 
                        "zip": "53105"
                    }, 
                    "name": "Department of Obstetrics & Gynecology, University Hospital Bonn"
                }, 
                "investigator": {
                    "last_name": "Michael Mallmann, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "marina.wirtz@uk-koeln.de", 
                    "last_name": "Marina Wirtz, MD", 
                    "phone": "+490221 4784910"
                }, 
                "facility": {
                    "address": {
                        "city": "Cologne", 
                        "country": "Germany", 
                        "zip": "50931"
                    }, 
                    "name": "Department of Obstetrics & Gynecology, University Hospital Cologne"
                }, 
                "investigator": {
                    "last_name": "Peter Mallmann, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "1", 
        "official_title": "Pilot Study for Tablet-based Questionnaire of Patient-reported Outcomes From Patients Undergoing Chemotherapy (TabPRO I)", 
        "overall_contact": {
            "email": "michael.mallmann@uni-bonn.de", 
            "last_name": "Michael Mallmann, MD", 
            "phone": "+49 (0) 228 287 15449"
        }, 
        "overall_official": {
            "affiliation": "Department of Obstetrics & Gynecology, University Hospital Bonn", 
            "last_name": "Michael Mallmann, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Feasibility of Tablet-based questionnaire of PRO (>60% of patients answer >60% of questionnaires in the time frame of study duration)", 
            "measure": "Feasibility of Tablet-based questionnaire of PRO", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "reference": [
            {
                "PMID": "17855485", 
                "citation": "Lipscomb J, Gotay CC, Snyder CF. Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J Clin. 2007 Sep-Oct;57(5):278-300. Review."
            }, 
            {
                "PMID": "9161115", 
                "citation": "Dancey J, Zee B, Osoba D, Whitehead M, Lu F, Kaizer L, Latreille J, Pater JL. Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res. 1997 Mar;6(2):151-8."
            }, 
            {
                "PMID": "17991929", 
                "citation": "Garcia SF, Cella D, Clauser SB, Flynn KE, Lad T, Lai JS, Reeve BB, Smith AW, Stone AA, Weinfurt K. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol. 2007 Nov 10;25(32):5106-12. Review. Erratum in: J Clin Oncol. 2008 Feb 20;26(6):1018. Lad, Thomas [added]."
            }, 
            {
                "PMID": "18048818", 
                "citation": "Basch E, Iasonos A, Barz A, Culkin A, Kris MG, Artz D, Fearn P, Speakman J, Farquhar R, Scher HI, McCabe M, Schrag D. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol. 2007 Dec 1;25(34):5374-80."
            }, 
            {
                "PMID": "10871716", 
                "citation": "Taenzer P, Bultz BD, Carlson LE, Speca M, DeGagne T, Olson K, Doll R, Rosberger Z. Impact of computerized quality of life screening on physician behaviour and patient satisfaction in lung cancer outpatients. Psychooncology. 2000 May-Jun;9(3):203-13."
            }, 
            {
                "PMID": "1583942", 
                "citation": "Roizen MF, Coalson D, Hayward RS, Schmittner J, Thisted RA, Apfelbaum JL, Stocking CB, Cassel CK, Pompei P, Ford DE, et al. Can patients use an automated questionnaire to define their current health status? Med Care. 1992 May;30(5 Suppl):MS74-84."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01991691"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital, Bonn", 
            "investigator_full_name": "Michael Mallmann, MD", 
            "investigator_title": "Coordinating Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Answered questionnaires per patient", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "University Hospital, Bonn", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Bonn", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}